While the MSCI World consumer staples sector is not the source of scorching growth, there are some decent growth opportunities. Let’s start by calibrating the drug retail industry within the consumer staples sector. We calculate the average year over year growth rate embedded in analyst estimates for all companies in the MSCI World drug retail industry. On, average over the next four years, the drug retail industry possess the highest top-line growth estimates of all industries.
Analyst revisions have also been on the upswing for the drug retail industry. Here we show the 3-month change in the level of growth estimates for each of the next four years.
Revisions breadth has also been strong in the drug retail industry, with 67% of the companies experiencing rising top-line estimates over the last three months.
Top line improvements have no doubt contributed to the drug retail industry turning in the second best performance within the consumer staples sector for the last three months.